Skip to main content

Table 2 Details on LHRH tests performed in 2019 and 2020

From: Reduction in pediatric growth hormone deficiency and increase in central precocious puberty diagnoses during COVID 19 pandemics

 

2019

2020

Normal

Pathological

Total

Normal

Pathological

Total

Suspected diagnosis

CPP

24 (50%)

24 (50%)

48

26 (49%)

28 (51%)

54

Females

22

16

38

19

26

45

Males

2

8

10

7

2

9

HH

13 (73%)

5 (27%)

18

26 (96%)

1 (4%)

27

 

Total

66

 

81

 
  1. CPP Central Precocious Puberty, HH Hypogonadotropic Hypogonadism